News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Wilson Marc
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/17/2023 |
4
| Wilson Marc (CFO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 1,666 shares
@ $17.12, valued at
$28.5k
|
|
| 03/02/2022 |
4
| Wilson Marc (CFO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Granted 19,500 shares
@ $0
Granted 91,000 options to buy
@ $20.02, valued at
$1.8M
|
|
| 03/02/2021 |
4
| Wilson Marc (CFO and Secretary) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Granted 114,000 options to buy
@ $15.29, valued at
$1.7M
|
|
| 02/26/2020 |
4
| Wilson Marc (CFO and Secretary) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Granted 70,000 options to buy
@ $22.61, valued at
$1.6M
|
|
| 03/12/2019 |
4
| Wilson Marc (CFO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Granted 56,250 options to buy
@ $25.19, valued at
$1.4M
|
|
| 07/17/2018 |
3
| Wilson Marc (See Remarks) has filed a Form 3 on Crinetics Pharmaceuticals, Inc. |
| 09/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2017 |
4
| Wilson Marc (Chief Accounting Officer) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 12,000 options to buy
@ $9.89, valued at
$118.7k
Granted 25,000 options to buy
@ $7.8, valued at
$195k
|
|
|
|